top of page

Selegiline transdermal (EMSAM)    

Visualize Pharmacology

Selegiline transdermal Emsam mnemonic mascot Yosemite Sam Seals gills

Selegiline transdermal (Emsam) is a monoamine oxidase inhibitor delivered through a skin patch for major depressive disorder in adults. The delivery route changes exposure compared with oral selegiline used for Parkinson’s disease.

Open selegiline transdermal in Ballicules.com console

Go to selegiline transdermal on ballicules.com

Selegiline transdermal ballicule illustrating monoamine oxidase inhibition

Mechanism and mnemonic

“YosEmite Sam Seals gills” connects Emsam with selegiline. The Mao Zedong cue on the patch recalls monoamine oxidase inhibition. The pegged decagon ballicule illustrates its pharmacology.

Selegiline transdermal CYP2B6 substrate interaction avatar

Interactions and formulation cautions

The interaction avatar illustrates CYP2B6 substrate metabolism. Serious pharmacodynamic interactions remain important, including serotonin toxicity with contraindicated serotonergic medications.

Tyramine dietary restrictions depend on patch strength and recent treatment changes. Drug-specific washout intervals are required when changing interacting medications.

Go to oral selegiline on ballicules.com

bottom of page